Patents by Inventor Nicholas Plotnikoff

Nicholas Plotnikoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR INDUCING A SUSTAINED IMMUNE RESPONSE
    Publication number: 20220370438
    Abstract: A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.01 and about 10 mg of naltrexone.
    Type: Application
    Filed: August 5, 2022
    Publication date: November 24, 2022
    Inventors: Noreen Griffin, Fengping Shan, Nicholas Plotnikoff
  • Method for inducing a sustained immune response
    Patent number: 11419865
    Abstract: A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.01 and about 10 mg of naltrexone.
    Type: Grant
    Filed: June 11, 2020
    Date of Patent: August 23, 2022
    Inventors: Noreen Griffin, Fengping Shan, Nicholas Plotnikoff
  • Method for Inducing a Sustained Immune Response
    Publication number: 20210069178
    Abstract: A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.
    Type: Application
    Filed: June 11, 2020
    Publication date: March 11, 2021
    Inventors: Noreen Griffin, Fengping Shan, Nicholas Plotnikoff
  • Method for inducing a sustained immune response
    Patent number: 10695343
    Abstract: A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.01 and about 10 mg of naltrexone.
    Type: Grant
    Filed: October 8, 2018
    Date of Patent: June 30, 2020
    Inventors: Noreen Griffin, Fengping Shan, Nicholas Plotnikoff
  • Method for Inducing a Sustained Immune Response
    Publication number: 20190321357
    Abstract: A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.
    Type: Application
    Filed: October 8, 2018
    Publication date: October 24, 2019
    Inventors: Noreen Griffin, Fengping Shan, Nicholas Plotnikoff
  • Method for inducing a sustained immune response
    Patent number: 10111870
    Abstract: A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.01 and about 10 mg of naltrexone.
    Type: Grant
    Filed: February 20, 2017
    Date of Patent: October 30, 2018
    Inventors: Noreen Griffin, Fengping Shan, Nicholas Plotnikoff
  • Method for Inducing a Sustained Immune Response
    Publication number: 20170239238
    Abstract: A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.
    Type: Application
    Filed: February 20, 2017
    Publication date: August 24, 2017
    Inventors: Noreen Griffin, Fengping Shan, Nicholas Plotnikoff
  • Method for Inducing a Sustained Immune Response
    Publication number: 20170239239
    Abstract: A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.
    Type: Application
    Filed: February 20, 2017
    Publication date: August 24, 2017
    Inventors: Noreen Griffin, Fengping Shan, Nicholas Plotnikoff